Biomarkers for Lupus Nephritis: A Critical Appraisal
Open Access
- 19 April 2010
- journal article
- review article
- Published by Hindawi Limited in Journal of Biomedicine and Biotechnology
- Vol. 2010, 1-11
- https://doi.org/10.1155/2010/638413
Abstract
Kidney disease is one of the most serious manifestations of systemic lupus erythematosus (SLE). Despite the improvement in the medical care of SLE in the past two decades, the prognosis of lupus nephritis remains unsatisfactory. Besides exploring more effective but less toxic treatment modalities that will further improve the remission rate, early detection and treatment of renal activity may spare patients from intensive immunosuppressive therapies and reduce renal damage. Conventional clinical parameters such as creatinine clearance, proteinuria, urine sediments, anti-dsDNA, and complement levels are not sensitive or specific enough for detecting ongoing disease activity in the lupus kidneys and early relapse of nephritis. Thus, novel biomarkers are necessary to enhance the diagnostic accuracy and sensitivity of lupus renal disease, prognostic stratification, monitoring of treatment response, and detection of early renal flares. This paper reviews promising biomarkers that have recently been evaluated in longitudinal studies of lupus nephritis.Keywords
This publication has 98 references indexed in Scilit:
- Elevated Urinary VCAM-1, P-Selectin, Soluble TNF Receptor-1, and CXC Chemokine Ligand 16 in Multiple Murine Lupus Strains and Human Lupus NephritisThe Journal of Immunology, 2007
- Anti-alpha-actinin antibodies: A new marker of lupus nephritisAutoimmunity Reviews, 2007
- Lipocalin-2, TWEAK, and Other Cytokines as Urinary Biomarkers for Lupus NephritisAnnals of the New York Academy of Sciences, 2007
- Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritisLupus, 2007
- Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flareInflammation Research, 2007
- Urinary lipocalin‐2 is associated with renal disease activity in human lupus nephritisArthritis & Rheumatism, 2007
- A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisoloneAnnals Of The Rheumatic Diseases, 2007
- Activation signal transduction by β1 integrin in T cells from patients with systemic lupus erythematosusArthritis & Rheumatism, 2007
- Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritisClinical Rheumatology, 2007
- Biomarker discovery in human SLE nephritis.2007